941
Views
29
CrossRef citations to date
0
Altmetric
Review Article

Dual use of electronic cigarettes and classic cigarettes: a systematic review

, , , &
Pages 330-338 | Received 09 Feb 2016, Accepted 29 Sep 2017, Published online: 06 Dec 2017

References

  • Action on Smoking and Health (ASHF). 2014. ASHF act sheet: use of electronic cigarettes in Great Britain.
  • Adkison SE, O’Connor RJ, Bansal-Travers M, Hyland A, Borland R, Yong HH, Cummings KM, McNeill A, Thrasher JF, Hammond D, Fong GT. 2013. Electronic nicotine delivery systems: international tobacco control four-country survey. Am J Prev Med. 44:207–215.
  • Babb S, Malarcher A, Schauer G, Asman K, Jamal A. 2017. Quitting smoking among adults: United States, 2000-2015. MMWR Morb Mortal Wkly Rep. 65:1457–1464.
  • Barrington-Trimis JL, Berhane K, Unger JB, Cruz TB, Huh J, Leventhal AM, Urman R, Wang K, Howland S, Gilreath TD, et al. 2015. Psychosocial factors associated with adolescent electronic cigarette and cigarette use. Pediatrics. 136: 308–317.
  • Bekki K, Uchiyama S, Ohta K, Inaba Y, Nakagome H, Kunugita N. 2014. Carbonyl compounds generated from electronic cigarettes. IJERPH. 11:11192–11200.
  • Biener L, Hargraves JL. 2014. A longitudinal study of electronic cigarette use in a population-based sample of adult smokers: association with smoking cessation and motivation to quit. Nicotine Tob Res. 9:13–19.
  • Borderud SP, Yuelin LI, Burkhalter JE, Sheffer CE, Ostroff JS. 2014. Electronic cigarette use among patients with cancer: characteristics of electronic cigarette users and their smoking cessation outcomes. Cancer. 120:3527–3535.
  • Bullen C, Howe C, Laugesen M, McRobbie H, Parag V, Williman J, Walker N. 2013. Electronic cigarettes for smoking cessation: A randomised controlled trial. Lancet. 382:1629–1637.
  • Caponnetto P, Auditore R, Russo C, Cappello GC, Polosa R. 2013. Impact of an electronic cigarette on smoking reduction and cessation in schizophrenic smokers: a prospective 12-month pilot study. IJERPH. 10:446–461.
  • Cibella F, Campagna D, Caponnetto P, Amaradio MD, Caruso M, Russo C, Cockcroft DW, Polosa R. 2016. Lung function and respiratory symptoms in a randomized smoking cessation trial of electronic cigarettes. Clin Sci. 130:1929–1937.
  • Caponnetto P, Campagna D, Cibella F, Morjaria JB, Caruso M, Russo C, Polosa R. 2013. EffiCiency and Safety of an eLectroniccigAreTte (ECLAT) as tobacco cigarettessubstitute: a prospective 12-month randomized control design study. PLoS One. 8:e66317.
  • DeJarnett N, Conklin DJ, Riggs DW, Myers JA, O’Toole TE, Hamzeh L, Wagner S, Chugh A, Ramos KS, Srivastava S, et al. 2014. Acrolein exposure is associated with increased cardiovascular disease risk. J Am Heart Assoc. 3:e000934.
  • Doll R, Peto R, Boreham J, Sutherland I. 2004. Mortality in relation to smoking: 50 years' observations on male British doctors. BMJ. 328:1519–1528.
  • Etter JF, Bullen C. 2014. A longitudinal study of electronic cigarette users. Addict Behav. 39:491–494.
  • Farsalinos KE, Romagna G, Voudris V. 2015. Factors associated with dual use of tobacco and electronic cigarettes: a case control study. Int J Drug Policy. 26: 595–600.
  • Farsalinos KE, Spyrou A, Tsimopoulou K, Stefopoulos C, Romagna G, Voudris V. 2014. Nicotine absorption from electronic cigarette use: comparison between first and new-generation devices. Sci Rep. 4:4133.
  • Farsalinos K, Cibella F, Caponnetto P, Campagna D, Morjaria JB, Battaglia E, Caurso M, Russo C, Polosa R. 2016. Effect of continuous smoking reduction and abstinence on blood pressure and heart rate in smokers switching to electronic cigarettes. Intern Emerg Med. 11:85–94.
  • Ferguson J, Bauld L, Chesterman J, Judge K. 2005. The English smoking treatment services: one-year outcomes. Addiction. 100:59–69.
  • Fiore M. (2008). Treating tobacco use and dependence: 2008 update: clinical practice guideline. Collingdale (PA): Diane Publishing.
  • Gerber Y, Myers V, Goldbourt U. 2012. Smoking reduction at midlife and lifetime mortality risk in men: a prospective cohort study. Am J Epidemiol. 175:1006–1012.
  • Gökbayrak NS, Paiva AL, Blissmer BJ, Prochaska JO. 2015. Predictors of relapse among smokers: transtheoretical effort variables, demographics, and smoking severity. Addict Behav. 42:176–179.
  • Goniewicz ML, Knysa KJ, Gawron M, Kosmider L, Sobczak A, Kurek J, Prokopowicz A, Jablonska-Czapla M, Rosik-Dulewska C, Havel C, et al. 2014. Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob Control. 23:133–139.
  • Goniewicz ML, Lingas EO, Hajek P. 2013. Patterns of electronic cigarette use and user beliefs about their safety and benefits: an internet survey. Drug Alcohol Rev. 32:133–140.
  • Hajek P, Stead LF, West R, Jarvis M, Lancaster T. 2009. Relapse prevention interventions for smoking cessation. Cochrane Database Syst Rev. 21(1):CD003999.
  • Hajek P, Etter JF, Benowitz N, McRobbie H. 2014. Electronic cigarettes: review of use, content, safety, effects on smokers, and potential for harm and benefit. Addiction. 109:1801–1810.
  • Hecht SS, Carmella SG, Le KA, Murphy SE, Li YS, Le C, Jensen J, Hatsukami DK. 2004. Effects of reduced cigarette smoking on levels of 1-hydroxypyrene in urine. Cancer Epidemiol Prevent Biomark. 13:834–842.
  • Hecht SS, Murphy SE, Carmella SG, Zimmerman CL, Losey L, Kramarczuk I, Roe MR, Puumala SS, Li YS, Jensen J, Hatsukami DK. 2004. Effects of reduced cigarette smoking on the uptake of a tobacco-specific lung carcinogen. J Natl Cancer Inst. 96:107–115.
  • Hughes JR, Carpenter MJ. 2005. The feasibility of smoking reduction: an update. Addiction. 100:1074–1789.
  • Hughes JR, Carpenter MJ. 2006. Does smoking reduction increase future cessation and decrease disease risk? A qualitative review. Nicotine Tob Res. 8:739–749.
  • Hunt WA, Barnett LW, Branch LG. 1971. Relapse ates in addiction programs. J Clin Psychol. 27:455–456.
  • Joseph AM, Hecht SS, Murphy SE, Lando H, Carmella SG, Gross M, Hatsukami DK. 2008. Smoking reduction fails to improve clinical and biological markers of cardiac disease: a randomized controlled trial. Nicotine Tob Res. 10:471–481.
  • Klesges RC, Ebbert JO, Morgan GD, Sherrill-Mittleman D, Asfar T, Talcott WG, DeBon M. 2011. Impact of differing definitions of dual tobacco use: implications for studying dual use and a call for operational definitions. Nicotine Tob Res. 13:523–531.
  • Kosmider L, Sobczak A, Fik M, Knysa J, Zaciera M, Kurek J, Goniewicz ML. 2014. Carbonyl compounds in electronic cigarette vapors-effects of nicotine solvent and battery output voltage. Nicotine Tob Res. 16:1319–1326.
  • Lee PN. 2013. The effect of reducing the number of cigarettes smoked on risk of lung cancer, COPD, cardiovascular disease and FEV(1)–a review. Regulat Toxicol Pharmacol. 67:372–381.
  • Lee S, Grana RA, Glantz S, A. 2014. Electronic cigarette use among Korean adolescents: a cross-sectional study of market penetration, dual use, and relationship to quit attempts and former smoking. J Adolesc Health. 54:684–690.
  • Lee YO, Hebert CJ, Nonnemaker JM, Kim AE. 2014. Multiple tobacco product use among adults in the United States: cigarettes, cigars, electronic cigarettes, hookah, smokeless tobacco, and snus. Prev Med. 62:14–19.
  • Martínez-Sánchez JM, Ballbè M, Fu M, Martín-Sánchez JC, Saltó E, Gottlieb M, Daynard R, Connolly GN, Fernández E. 2014. Electronic cigarette use among adult population: a cross-sectional study in Barcelona, Spain (2013–2014). BMJ Open. 4:005894.
  • McRobbie H, Bullen C, Hartmann-Boyce J, Hajek P. 2014. Electronic cigarettes for smoking cessation and reduction (Review). Cochrane Database Syst Rev. 12:CD010216.
  • McRobbie H, Phillips A, Goniewicz ML, Smith KM, Knight-West O, Przulj D, Hajek P. 2015. Effects of switching to electronic cigarettes with and without concurrent smoking on exposure to nicotine, carbon monoxide, and acrolein. CancerPrev Res. 8:873–878.
  • Moretto N, Volpi G, Pastore F, Facchinetti F. 2012. Acrolein effects in pulmonary cells: relevance to chronic obstructive pulmonary disease. Ann NYA Cad Sci. 1259:39–46.
  • Nicholson AK, Borland R, Davey ME, Stevens M, Thomas DP. 2015. Past quit attempts in a national sample of Aboriginal and Torres Strait Islander smokers. Med J Aust. 202:S20–S25.
  • O’Connell G, Graff DW, D’Ruiz CD. 2016. Reductions in biomarkers of exposure (BoE) to harmful or potentially harmful constituents (HPHCs) following partial or complete substitution of cigarettes with electronic cigarettes in adult smokers. Toxicol Mech Methods. 26:453–464.
  • O’Connor RJ. 2012. Non-cigarette tobacco products: what have we learned and where are we headed? Tob Control. 21:181–190.
  • Ohta K, Uchiyama S, Naba Y, Nakagome H, Kunugita N. 2011. Determination of carbonyl compounds generated from theelectronic cigarette using coupled silica cartridges impregnated with hydroquinone and 2,4-Dinitrophenylhydrazine. Bunseki Kagaku. 60:791–797.
  • Palazzolo DL. 2013. Electronic cigarettes and vaping: a new challenge in clinical medicine and public health. A literature review. Front Public Health. 1:56.
  • Park YS, Taniguchi N. 2008. Acrolein induces inflammatory response under lying endothelial dysfunction. A risk factor for atherosclerosis. Ann NYA Cad Sci. 1126:185–189.
  • Pearson JL, Richardson A, Niaura RS, Vallone DM, Abrams DB. 2012. e-Cigarette awareness, use, and harm perceptions in US adults. Am J Public Health. 102:1758–1766.
  • Pokhrel P, Herzog TA, Muranaka N, Fagan P. 2015. Young adult e-cigarette users' reasons for liking and not liking e-cigarettes: a qualitative study. Psychol Health. 15:1–20.
  • Polosa R, Morjaria J, Caponnetto P, Caruso M, Strano S, Battaglia E, Russo C. 2014. Effect of smoking abstinence and reduction in asthmatic smokers switching to electronic cigarettes: evidence for harm reversal. IJERPH. 11:4965–4977.
  • Polosa R, Morjaria JB, Caponnetto P, Prosperini U, Russo C, Pennisi A, Bruno CM. 2016. Evidence for harm reduction in COPD smokers who switch to electronic cigarettes. Respir Res. 17:166.
  • Polosa R, Morjaria JB, Caponnetto P, Caruso M, Campagna D, Amaradio MD, Ciampi G, Russo C, Fisichella A. 2016. Persisting long term benefits of smoking abstinence and reduction in asthmatic smokers who have switched to electronic cigarettes. Discov Med. 21:99–108.
  • Polosa R, Morjaria JB, Caponnetto P, Battaglia E, Russo C, Ciampi C, Adams G, Bruno CM. 2016. Blood pressure control in smokers with arterial hypertension who switched to electronic cigarettes. IJERPH. 13:1123.
  • Pulvers K, Hayes RB, Scheuermann TS, Romero DR, Emami AS, Resnicow K, Olendzki E, Person SD, Ahluwalia JS. 2015. Tobacco use, quitting behavior, and health characteristics among current electronic cigarette users in a national tri-ethnic adult stable smoker sample. NICTOB Res. 17:1085–1095.
  • Rahman MA, Hann N, Wilson A, Mnatzaganian G, Worrall-Carter L. 2015. E-cigarettes and smoking cessation: evidence from a systematic review and meta-analysis. PLoS One. 10:e0122544.
  • Rass O, Pacek LR, Johnson PS, Johnson MW. 2015. Characterizing use patterns and perceptions of relative harm in dual users of electronic and tobacco cigarettes. Exp Clin Psycopharmacol. 23:494–503.
  • Regan AK, Promoff G, Dube SR, Arrazola R. 2013. Electronic nicotine delivery systems: adult use and awareness of the e-cigarette in the USA. Tob Control. 22:19–23.
  • Russo C, Cibella F, Caponnetto P, Campagna D, Maglia M, Frazzetto E, Mondati E, Caurso M, Polosa R. 2016. Evaluation of post cessation weight gain in a 1-year randomized smoking cessation trial of electronic cigarettes. Sci Rep. 6:18763.
  • Rutten LJ, Blake KD, Agunwamba AA, Grana RA, Wilson PM, Ebbert JO, Leischow SJ. 2015. Use of e-cigarettes among current smokers: associations among reasons for use, quit intentions, and current tobacco use. Nicotine Tob Res. 17:1228–1234.
  • Scanlon PD, Connett JE, Waller LA, Altose MD, Bailey WC, Sonia Buist A; e Lung Health Study Research Group. 2000. Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung health study. Am J Respir Crit Care Med. 161:381–390.
  • Shi R, Rickett T, Sun W. 2011. Acrolein-mediated injuryin nervous system trauma and diseases. Mol Nutr Food Res. 55:1320–1331.
  • Siegel MB, Tanwar KL, Wood KS. 2011. Electronic cigarettes as a smoking-cessation: tool results from an online survey. Am J Prev Med. 40:472–475.
  • Stead LF, Perera R, Bullen C, Mant D, Lancaster T. 2008. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 11:CD000146.
  • Stead LF, Lancaster T. 2007. Interventions to reduce harm from continued tobacco use. Cochrane Database Syst Rev. 18(3):CD005231.
  • Stevens JF, Maier CS. 2008. Acrolein: sources, metabolism, and biomolecular interactions relevant to human health and disease. Mol Nutr Food Res. 52:7–25.
  • Tverdal A, Bjartveit K. 2006. Health consequences of reduced daily cigarette consumption. Tob Control. 15:472–480.
  • US Centers for Disease Control and Prevention (USCDCP). 2013. Notes from the field: electronic cigarette use among middle and high school students United States, 2011-2012. MMWR Morb Mortal Wkly Rep. 62:729–730.
  • US Department of Health and Human Services (USHHS). (2004). The health consequences of smoking: a report of the surgeon general. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health.
  • Walker N, Bullen C, Mc Robbie H. 2009. Reduced Nicotine content cigarettes: is there potential to aid smoking cessation? Nicotine Tob Res. 11:1274–1279.
  • Wills TA, Knight R, Williams RJ, Pagano I, Sargent JD. 2015. Risk factors for exclusive E-cigarette use and dual E-cigarette use and tobacco use in adolescents. Pediatricts. 135:43–51.
  • Wollscheid KA, Kremzner ME. 2009. Electronic cigarettes: safety concerns and regulatory issues. Am J Health Syst Pharm. 66:1740–1742.
  • World Health Organization (WHO). 2003. WHO Framework Convention on Tobacco Control. ISBN: 9241591013.
  • World Health Organization (WHO). (2011). Tobacco Fact Sheet N339, May 2011.
  • Yeomans K, Payne KA, Marton JP, Merikle EP, Proskorovsky I, Zou KH, Li Q, Willke RJ. 2011. Smoking, smoking cessation and smoking relapse patterns: a web-based survey of current and former smokers in the US. Int J Clin Pract. 65:1043–1054.
  • Yuan JM, Gao YT, Wang R, Chen M, Carmella SG, Hecht SS. 2012. Urinary levels of volatile organic carcinogen and toxicant biomarkers in relation to lung cancer development in smokers. Carcinogenesis. 33:804–809.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.